This site is intended for Healthcare professionals only.

Zydus Cadila gets USFDA nod to market acne drug

Zydus Cadila gets USFDA nod to market acne drug

New Delhi: Drug firm Zydus Cadila Saturday said it has received the final nod from the US health regulator to market Clindamycin Phosphate and Benzoyl Peroxide gel, used in the treatment of acne. This combination medication is used to treat a certain type of acne (inflammatory acne vulgaris), the company said in a BSE filing. It also helps to decrease the number of acne pimples.

Read Also: Zydus Cadila gets USFDA nod for Doxycycline Hyclate delayed-release tablets, Febuxostat tablets

“Zydus Cadila has received the final approval from the USFDA to market Clindamycin Phosphate and Benzoyl Peroxide Gel, (US RLD -DUAC® Gel), 1.2 per cent/5 per cent.

“It will be manufactured at the group’s Topical manufacturing facility at Ahmedabad,” it added.

Clindamycin is an antibiotic that stops the growth of acne-causing bacteria. Benzoyl peroxide can also stop the growth of bacteria as well as reduce oil production in the skin, it further said.

Read Also: Zydus Cadila gets USFDA nod to market Albendazole Tablets

The following two tabs change content below.
MD Team

MD Team

At Medical Dialogues, we are a team of young professionals strongly advocating of the transparency in the medical sector through the free flow of medical information, health and medical news. MD Team covers a variety of news related to the healthcare, pharma and medical device industry in India. Our team can be contacted at Contact no. 011-43720751

Source: PTI
0 comment(s) on Zydus Cadila gets USFDA nod to market acne drug

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted